"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Dr. Reddy's Laboratories Inc.","Dr. Reddy's Laboratories","$5,000,000","$0","$5,000,000","2018","20180119","safety-related offenses","drug or medical equipment safety violation","","A federal court in New Jersey imposed a $5 million civil penalty and entered a consent decree of permanent injunction against Dr. Reddy's Laboratories Inc., the North American subsidiary of Dr. Reddy's Laboratories Limited, a pharmaceutical company headquartered in India. The case involved allegations that Dr. Reddy's failed to comply with the Poison Prevention Packaging Act and the Consumer Product Safety Act.","federal","agency action","Justice Department Civil Division","civil","","","","","","","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/district-court-awards-5-million-civil-penalties-and-enters-permanent-injunction-prevent-dr",""
